Total debt rose to $409.0M against cash of $75.6M and a debt-to-equity ratio of 2.22, suggesting the capital structure is weakening even as the current ratio of 3.97 appears comfortable on paper.
Adaptive Biotechnologies Corporation (ADPT) balance sheet — 9-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 |
|---|
| Total Current Assets | 392.69M | 300.19M | 283.75M | 410.19M | 562.15M | 402.75M | 726.91M | 612.69M | 180.72M | 205.25M |
| Cash & Short-Term Investments | 298.95M | 226.98M | 222.29M | 346.4M | 498.2M | 353.06M | 688.27M | 576.87M | 165.02M | 192.15M |
| Cash Only | 75.61M | 70.5M | 47.92M | 65.06M | 90.03M | 139.06M | 123.44M | 96.58M | 55.03M | 85.31M |
| Short-Term Investments | 223.34M | 156.49M | 174.37M | 281.34M | 408.17M | 214M | 564.83M | 480.29M | 109.99M | 106.84M |
| Accounts Receivable | 66.67M | 50.37M | 41.73M | 37.97M | 40.06M | 17.41M | 10.05M | 12.68M | 4.81M | 5.58M |
| Days Sales Outstanding | 65.79 | 66.37 | 85.11 | 81.39 | 78.9 | 41.17 | 37.27 | 54.39 | 31.52 | 52.99 |
| Inventory | 10.05M | 9.82M | 8.44M | 14.45M | 14.45M | 19.26M | 14.06M | 9.07M | 7.84M | 4.79M |
| Days Inventory Outstanding | 48.98 | 50.23 | 42.74 | 69.8 | 91.1 | 142.61 | 227.83 | 148.61 | 145.46 | 111.55 |
| Other Current Assets | 17.01M | 13.02M | 11.29M | 11.37M | 9.44M | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 290.43M | 212.55M | 255.62M | 250.95M | 294.47M | 520.6M | 389.5M | 299.61M | 151.97M | 157.24M |
| Property, Plant & Equipment | 65.96M | 74.72M | 94.38M | 120.32M | 164.21M | 172.94M | 139.04M | 60.35M | 19.13M | 13.95M |
| Fixed Asset Turnover | 4.25x | 3.71x | 1.90x | 1.42x | 1.13x | 0.89x | 0.71x | 1.41x | 2.91x | 2.76x |
| Goodwill | 118.97M | 118.97M | 118.97M | 118.97M | 118.97M | 118.97M | 118.97M | 118.97M | 118.97M | 118.97M |
| Intangible Assets | 456K | 1.73M | 3.42M | 5.13M | 6.83M | 8.53M | 10.22M | 11.93M | 13.63M | 15.32M |
| Long-Term Investments | 147.36M | 15.92M | 33.66M | 0 | 0 | 217.15M | 118.53M | 105.44M | 247K | 8.9M |
| Other Non-Current Assets | 3.82M | 1.21M | 5.18M | 6.52M | 4.46M | 3.01M | 2.74M | 2.92M | 247K | 86K |
| Total Assets | 683.12M | 512.74M | 539.38M | 661.13M | 856.62M | 923.34M | 1.12B | 912.3M | 332.69M | 362.49M |
| Asset Turnover | 0.51x | 0.54x | 0.33x | 0.26x | 0.22x | 0.17x | 0.09x | 0.09x | 0.17x | 0.11x |
| Asset Growth % | 62.34% | -4.94% | -18.42% | -22.82% | -7.23% | -17.29% | 22.37% | 174.22% | -8.22% | - |
| Total Current Liabilities | 98.97M | 89.92M | 98.05M | 88.02M | 109.79M | 113.81M | 105.2M | 78.31M | 22.8M | 21M |
| Accounts Payable | 6.53M | 6.47M | 7.26M | 7.72M | 8.08M | 3.31M | 3.24M | 4.45M | 1.79M | 1.96M |
| Days Payables Outstanding | 32.81 | 33.08 | 36.79 | 37.29 | 50.95 | 24.48 | 52.44 | 72.97 | 33.27 | 45.72 |
| Short-Term Debt | 0 | 13.56M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 207.84M | 45.19M | 55.69M | 48.63M | 64.11M | 80.46M | 73.32M | 60.99M | 12.7M | 14.05M |
| Other Current Liabilities | 0 | 7.7M | 16.7M | 13.69M | 15.94M | 15.64M | 11.95M | 8.49M | 3.67M | 1.93M |
| Current Ratio | 3.97x | 3.34x | 2.89x | 4.66x | 5.12x | 3.54x | 6.91x | 7.82x | 7.93x | 9.77x |
| Quick Ratio | 3.87x | 3.23x | 2.81x | 4.50x | 4.99x | 3.37x | 6.78x | 7.71x | 7.58x | 9.54x |
| Cash Conversion Cycle | 81.96 | 83.52 | 91.06 | 113.9 | 119.04 | 159.3 | 212.66 | 130.03 | 143.7 | 118.82 |
| Total Non-Current Liabilities | 400.26M | 197.82M | 238.84M | 264.84M | 282.73M | 205.44M | 267.95M | 262.95M | 568M | 566.1M |
| Long-Term Debt | 335.38M | 196.79M | 0 | 0 | 0 | 0 | 0 | 0 | 561.19M | 0 |
| Capital Lease Obligations | 270.6M | 70.23M | 79.15M | 89.39M | 98.77M | 106.69M | 104.33M | 36.61M | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -561.19M | 0 |
| Other Non-Current Liabilities | 20K | -70.21M | 132.43M | 130.66M | 125.36M | 0 | 0 | 7.01M | 6.1M | 566.1M |
| Total Liabilities | 499.23M | 287.74M | 336.89M | 352.86M | 392.52M | 319.24M | 373.15M | 341.26M | 590.8M | 587.11M |
| Total Debt | 408.97M | 280.58M | 89.39M | 98.77M | 108M | 111.74M | 107.86M | 36.61M | 561.19M | 561.67M |
| Net Debt | 333.36M | 210.09M | 41.47M | 33.71M | 17.97M | -27.32M | -15.57M | -59.97M | 506.16M | 476.37M |
| Debt / Equity | 2.22x | 1.25x | 0.44x | 0.32x | 0.23x | 0.18x | 0.15x | 0.06x | - | - |
| Debt / EBITDA | -12.44x | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | -10.14x | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -4.99x | -4.05x | -12.78x | -15.33x | -46.28x | - | - | - | - | - |
| Total Equity | 183.89M | 225M | 202.49M | 308.28M | 464.1M | 604.1M | 743.27M | 571.04M | -258.11M | -224.62M |
| Equity Growth % | 2.95% | 11.12% | -34.32% | -33.57% | -23.18% | -18.72% | 30.16% | 321.24% | -14.91% | - |
| Book Value per Share | 0.98 | 1.48 | 1.38 | 2.14 | 3.26 | 4.30 | 5.66 | 4.59 | -2.45 | -2.13 |
| Total Shareholders' Equity | 176.21M | 218.79M | 202.71M | 308.4M | 464.17M | 603.99M | 743.27M | 571.04M | -258.11M | -224.62M |
| Common Stock | 16K | 15K | 14K | 14K | 14K | 14K | 14K | 12K | 1K | 1K |
| Retained Earnings | -1.42B | -1.36B | -1.3B | -1.14B | -919.08M | -718.89M | -511.61M | -365.48M | -295.91M | -249.42M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -1.28M | 253K | 166K | 215K | -4.12M | -1.14M | 893K | 671K | -107K | -166K |
| Minority Interest | 7.68M | 6.21M | -224K | -121K | -67K | 110K | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying ADPT stock.
As of 2025, Adaptive Biotechnologies Corporation (ADPT) had total assets of $512.7M including $300.2M in current assets.
Adaptive Biotechnologies Corporation (ADPT) carries total debt of $280.6M, offset by $227.0M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Adaptive Biotechnologies Corporation (ADPT) has total shareholders' equity (book value) of $218.8M ($1.48 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Adaptive Biotechnologies Corporation (ADPT) reported a current ratio of 3.34x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Thin liquidity against debt
Metrics are mathematically derived from official filings.
Leverage Rising as Cash Lags Growth
Based on reported quarterly balance sheets, ADPT's total debt climbed from $84.4M in 2025Q2 to $409.0M in 2026Q3 while cash fell to $75.6M, a mismatch that suggests the balance sheet is weakening even as the top line expands.
The jump in debt to $409.0M against roughly $176M of equity lifts debt-to-equity to 2.22, a sharp reversal from the sub-0.5 leverage seen through most of 2025. This pattern may indicate that the company is financing operations with borrowings rather than internally generated cash, which investors should monitor closely. Whether this reflects strategic capital deployment or a necessity-driven funding gap warrants further investigation of the debt agreements.
Debt Surge Outpaces Liquidity Buffer
According to recent SEC filings, ADPT's debt reached $410.5M in 2026Q2 against cash of $169.9M, leaving a gap that a company still posting negative trailing margins may find difficult to close without new financing.
Debt-to-equity peaked at 2.72 in 2026Q2 before easing to 2.22, but the level remains high for a company with a trailing operating margin of -20.6%. Refinancing risk and covenant exposure cannot be assessed from the supplied data, and the absence of maturity or interest detail limits conclusions. The debt load appears to depend on sustained revenue execution to remain serviceable.
Current Ratio Strong, Cash Thin
As reported in financial statements, ADPT's current ratio of 3.97 in 2026Q3 looks comfortable on paper, yet cash of $75.6M is modest relative to the company's ongoing operating losses and debt service needs.
A current ratio near 4 suggests short-term assets comfortably exceed short-term obligations, but the composition of current assets is not disclosed and may be weighted toward receivables rather than cash. Given that cash has ranged between $38M and $170M over the period, the liquidity runway appears limited relative to burn. Investors should treat the ratio as a partial signal and focus on cash conversion.
Accumulated Deficit Dwarfs Shareholder Equity
Based on EDBL's reported figures, retained earnings sit near -$1.4B against equity of only $176.2M, indicating that cumulative losses have consumed the vast majority of capital contributed by shareholders over time.
Equity has compressed from $241.6M in 2024Q2 to $176.2M in 2026Q3, consistent with persistent losses that have not been offset by profitability. The scale of the accumulated deficit implies that any future equity raise would likely be dilutive to existing holders. Stock-based compensation and share issuance are not fully visible in this dataset, so the true dilution profile remains uncertain.
Reported Equity Stability May Mask Risk
Headline leverage metrics may understate the true balance sheet pressure, as deferred revenue of $60.4M and recent debt additions are not reflected in any single ratio and could alter the apparent liquidity picture.
Deferred revenue has risen from $42.5M to $60.4M over recent quarters, which may represent customer prepayments that improve near-term cash but create future performance obligations. Conversely, the debt added in 2026 may carry terms not visible in the summary data. Interpreting the current ratio without separating restricted or non-cash current assets could overstate true liquidity.